Efficacy and Safety of Neoadjuvant Chemotherapy with or without Immune Checkpoint Inhibitors for Resectable Esophageal Squamous Cell Carcinoma: a Meta-analysis of Randomized Controlled Trials

Ting Zheng(Beijing Institute of Technology), Jianjiang Jin(Hangzhou First People's Hospital), Xingxing Li(Hangzhou First People's Hospital)
Journal of Gastrointestinal Cancer
August 11, 2025
Cited by 0


Related Papers